Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
03/20/1996 | EP0701439A1 Stable copper(i) complexes and methods related thereto |
03/20/1996 | EP0701434A1 Preparations containing silicon dioxide to improve the taste thereof |
03/20/1996 | EP0656776B1 Multilayer controlled release tablets containing both naproxen and naproxen sodium salt |
03/20/1996 | EP0489072B1 Treatment of chronic inflammatory conditions |
03/20/1996 | CN1119019A Compositions and methods for the treatment of immunomediated inflammatory disorders |
03/20/1996 | CN1118989A Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof |
03/20/1996 | CA2158517A1 Aminomethylphosphonic and aminomethylphosponic acid derivates and their use for treating degenerative joint disorders |
03/19/1996 | US5500429 Cardiovascular |
03/19/1996 | US5500417 Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents |
03/19/1996 | CA2109800C N-hydroxyurea derivatives which inhibit lipoxygenase |
03/17/1996 | CA2158222A1 Use of substituted cyclopentane- di- and triones |
03/14/1996 | WO1996007739A2 Interleukin-1 type 3 receptors |
03/14/1996 | WO1996007658A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
03/14/1996 | WO1996007657A1 Pyrimido[5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them |
03/14/1996 | WO1996007651A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
03/14/1996 | WO1996007649A1 Morpholine derivatives and their use as therapeutic agents |
03/14/1996 | WO1996007424A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response |
03/14/1996 | CA2199609A1 Interleukin-1 type 3 receptors |
03/14/1996 | CA2198477A1 Morpholine derivatives and their use as therapeutic agents |
03/14/1996 | CA2198018A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response |
03/13/1996 | EP0700387A1 Salts of substituted heteroaromatic nitrogen compounds, method for their preparation and pharmaceutical compounds containing same |
03/13/1996 | EP0700304A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
03/13/1996 | EP0700301A1 Peptides and compounds that bind to elam-1 |
03/13/1996 | EP0690841A4 Synthetic matrix metalloprotease inhibitors and uses thereof |
03/13/1996 | EP0618899B1 Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase |
03/13/1996 | EP0544880B1 Method of preparing diacetyl rhein |
03/13/1996 | EP0489108B1 Use of spiperone derivatives for immunosuppression |
03/13/1996 | CN1031266C Process for preparation of heterocycle ether derivatives |
03/12/1996 | US5498729 Prodrug compositions |
03/12/1996 | US5498405 Indole alkaloids useful as UV protective and anti-inflammatory agents |
03/07/1996 | WO1996006941A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
03/07/1996 | WO1996006937A1 Improvements in production of proteins in host cells |
03/07/1996 | WO1996006840A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
03/07/1996 | WO1996006640A1 Bioadhesive-wound healing composition |
03/07/1996 | WO1996006630A1 Methods and compositions for modulating a t cell response |
03/07/1996 | WO1996006607A1 Indole alkaloids useful as uv protective and anti-inflammatory agents |
03/07/1996 | WO1996006528A1 Ionene polymers containing biologically-active anions |
03/07/1996 | CA2198462A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
03/07/1996 | CA2198345A1 Improvements in production of proteins in host cells |
03/07/1996 | CA2197895A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
03/07/1996 | CA2194876A1 Bioadhesive-wound healing composition |
03/06/1996 | EP0699679A1 Tetrahydropyranyl compounds, process for their preparation and pharmaceutical compositions containing them |
03/06/1996 | EP0699674A1 1-Aryl-2-acetylamidopentanone derivatives for use as tachykinin receptor antagonists |
03/06/1996 | EP0699444A2 Composition for the treatment of intestinal wounds or ulcers containing proteins, carbohydrates and fat |
03/06/1996 | EP0699436A1 Controlled release formulation |
03/06/1996 | EP0699199A1 Heteroatom substituted alkyl benzylaminoquinuclidines as substance p antagonists |
03/06/1996 | EP0699195A1 Thioindole pyperidinyl derivatives used as antalgics |
03/06/1996 | EP0699192A1 Substituted oxazolyl compounds for the treatment of inflammation |
03/06/1996 | EP0699191A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
03/06/1996 | EP0699188A1 Quinoline derivatives as leukotriene antagonists |
03/06/1996 | EP0699180A1 Bicyclic amide derivatives and their use as muscle relaxants |
03/06/1996 | EP0587723B1 Quinuclidine derivatives |
03/06/1996 | EP0395653B1 Synovial phospholipases |
03/06/1996 | CN1118141A Combination of a soluble complement receptor -1(SCR1) and an amidinophenyl or amidinonaphthyl-ester for treating inflammation |
03/06/1996 | CN1117874A Nasally administrable compositions |
03/06/1996 | CN1031193C Polypeptide and method for preparing same |
03/05/1996 | US5496950 Antiinflammatory agents |
03/05/1996 | US5496851 Antiinflammatory, anticoagulants |
03/05/1996 | US5496828 Methods of inhibiting ulcerative mucositis |
03/01/1996 | CA2157156A1 New tetrahydropyranic compounds, process for their preparation and pharmaceutical composition containing them |
02/29/1996 | WO1996006169A1 Human chemokine beta-9 |
02/29/1996 | WO1996006114A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
02/29/1996 | WO1996006095A1 Endothelin antagonists |
02/29/1996 | WO1996006094A1 Novel substituted piperidines useful for the treatment of allergic diseases |
02/29/1996 | WO1996006093A1 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands |
02/29/1996 | WO1996006083A1 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists |
02/29/1996 | WO1996006082A1 Dihydropyridine derivatives as bradykinin antagonists |
02/29/1996 | WO1996006078A1 N-(2-(pyrrolidinyl-1)-1-phenylethyl)acetamides as kappa receptor antagonists |
02/29/1996 | WO1996006077A1 N-[2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor antagonists |
02/29/1996 | WO1996006074A1 Metalloproteinase inhibitors |
02/29/1996 | WO1996005863A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
02/29/1996 | WO1996005856A1 Human chemokine polypeptides |
02/29/1996 | WO1996005838A2 Combined preparation for the therapy of immune diseases |
02/29/1996 | WO1996005834A1 Improved pharmaceutical formulations containing ibuprofen and codeine |
02/29/1996 | WO1996005831A1 Methods of inhibiting ulcerative mucositis |
02/29/1996 | DE4430601A1 Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander Cell adhesion peptides to modify the adhesion behavior of eukaryotic cells between each other |
02/29/1996 | DE4430128A1 Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen Combination with immunosuppressive drug, cardiovascular and cerebral effects |
02/29/1996 | CA2517691A1 Endothelin antagonists |
02/29/1996 | CA2198207A1 Cell adhesion peptides for use in modifying mutual adhesion among eukaryotic cells |
02/29/1996 | CA2198206A1 Human chemokine beta-9 |
02/29/1996 | CA2198016A1 Methods of inhibiting ulcerative mucositis |
02/29/1996 | CA2196979A1 7-azabicyclo¬2.2.1|-heptane and -heptene derivatives as cholinergic receptor ligands |
02/28/1996 | EP0698594A1 Pharmaceutical anthraquinone derivatives |
02/28/1996 | EP0698031A1 SIALYL LE x ANALOGUES AS INHIBITORS OF CELLULAR ADHESION |
02/28/1996 | EP0697880A1 Inhibition of leukocyte adhesion |
02/28/1996 | EP0697873A1 Olefin-substituted long chain compounds |
02/28/1996 | EP0697868A1 Methods and compositions using optically pure (+)-zileuton |
02/28/1996 | EP0697864A1 Treatment of septic shock |
02/28/1996 | EP0588897B1 Non-chlorofluorocarbon aerosol formulations |
02/28/1996 | EP0547224B1 14-O-p-CHLOROBENZOYLACONINE AND ANALGESIC/ANTIINFLAMMATORY AGENT |
02/28/1996 | CN1117484A Fatty acid derivatives |
02/28/1996 | CN1031132C Process for preparation of carbocyclic adenosine analogs useful as immunosuppressants |
02/27/1996 | US5494927 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
02/27/1996 | CA2155447A1 Substituted biphenyl isoxazole sulfonamides |
02/27/1996 | CA2046970C Anti-inflammatory composite |
02/27/1996 | CA2030204C Pharmaceutical compositions of tebufelone |
02/27/1996 | CA1338083C Ozonides of terpenes and their medical uses |
02/25/1996 | CA2156700A1 Pharmaceutical compounds |
02/24/1996 | CA2156768A1 Pharmaceutical formulations, their preparation and use |
02/22/1996 | WO1996005221A1 Calcitonin receptor |